Navigation Links
Researchers step closer to treatment of virulent hospital infection
Date:3/18/2011

Clostridium difficile is a health problem that affects hundreds of thousands of patients and costs $10 billion to $20 billion every year in North America. Researchers from the University of Calgary and the National Research Council of Canada say they are gaining a deeper understanding of this disease and are closer to developing a novel treatment using antibodies from llamas.

"We have found that relatively simple antibodies can interfere with the disease-causing toxins from C. difficile," says paper co-author Dr. Kenneth Ng, an associate professor of biological sciences at the University of Calgary and principal investigator of the Alberta Ingenuity Centre for Carbohydrate Science. "This discovery moves us a step closer to understanding how to neutralize the toxins and to create novel treatments for the disease." His research is part of a paper published today in the print issue of the Journal of Biological Chemistry.

Approximately two percent of all patients admitted to hospital may be infected by C. difficile, which thrives when healthy bacteria in the gut are weakened by antibiotics, thus allowing spores from Clostridium to germinate and colonize the large intestine.

"This research is significant because C. difficile is an increasing heath care problem and many people may experience multiple infections," says Dr. Glen Armstrong, head of the Department of Microbiology, Immunology, and Infectious Diseases in the Faculty of Medicine at the University of Calgary. "The current treatments are becoming less effective and C. difficile is developing resistance to conventional antibiotics. This research promises to provide a much-needed alternate treatment option that will overcome the failings of conventional antibiotics."

C. difficile produces two toxins -- toxin A (TcdA) and toxin B (TcdB) -- which cause damage to intestinal cells by binding to carbohydrates on the cell surface
'/>"/>

Contact: Leanne Yohemas
leanne.yohemas@ucalgary.ca
403-540-6552
University of Calgary
Source:Eurekalert  

Page: 1 2

Related biology news :

1. UCLA researchers engineer E. coli to produce record-setting amounts of alternative fuel
2. Hopkins researchers use light to move molecules
3. Zoo researchers provide African sanctuaries road map
4. Brandeis researchers use lasers, custom microscope to show gene splicing process in real time
5. Synthetic biology: TUM researchers develop novel kind of fluorescent protein
6. Researchers find drug that stops progression of Parkinsons disease in mice
7. Researchers discover new wintering grounds for humpback whales using sound
8. Berkeley Lab researchers illuminate laminins role in cancer formation
9. Researchers discover new shapes of microcompartments
10. Researchers find possible new treatment strategies for pancreatic cancer
11. Scripps oceanography researchers discover arctic blooms occurring earlier
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers step closer to treatment of virulent hospital infection
(Date:7/9/2014)... global census of Adlie penguins shows that the ... percent larger than previously estimated. Adlie penguins have ... monitor and understand the effects of climate change ... using high-resolution satellite imagery, researchers from Stony Brook ... new method that permits regular monitoring of Adlie ...
(Date:7/9/2014)... U.S. may be on the verge of an economy driven ... cleaner than coal and is undergoing a production boom. It ... but recent research is casting serious doubts over just how ... & Engineering News (C&EN), the weekly news magazine of ... a senior correspondent at C&EN, explains that when burned as ...
(Date:7/9/2014)... drug candidate developed by researchers at the ... (NCATS) and its collaborators to treat sickle ... International,s BioScience business. The drug candidate, Aes-103, ... the underlying molecular mechanism of sickle cell ... development activities required for regulatory approval and ...
Breaking Biology News(10 mins):New study finds that Adélie penguin population is on the rise 2New study finds that Adélie penguin population is on the rise 3First drug candidate from NIH program acquired by biopharmaceutical company 2First drug candidate from NIH program acquired by biopharmaceutical company 3First drug candidate from NIH program acquired by biopharmaceutical company 4
... Michel Boufadel has been appointed a member of a National ... Daily Recovery Capacity. The appointment is through Nov. 14, ... techniques for skimming oil off the ocean surface following spills. ... oil spills. Boufadel has been a notable voice in ...
... 27, 2013 Elsevier, a world-leading provider of scientific, ... the launch of a new open access journal ... the International Water Association (IWA). The first issue of ... better water governance and sustainable development". All articles are ...
... who carry a gene for a specific protein face a ... study published in mBio , the online open-access journal ... neoformans is the most common cause of fungal meningitis ... everyone with HIV who has a very low level of ...
Cached Biology News:NJIT professor appointed to National Research Council 2Elsevier announces the launch of a new open access journal: Water Resources and Industry 2Gene makes some HIV-infected patients more at risk for fungal disease 2Gene makes some HIV-infected patients more at risk for fungal disease 3
(Date:1/15/2014)... England and SAN JOSE, California ... international biotechnology company developing antibody-drug conjugates for cancer, today announced ... Board of Directors. Dr Reynolds has over 20 years, development ... Medical Officer at Seattle Genetics. "I am delighted ...
(Date:1/15/2014)... 2014 More than 5 million Americans ... in 3 seniors will die with Alzheimer’s or another ... figures have shocked many Americans into looking for ways ... these tragic age-related cognitive disorders. Jonathan Weisman, president of ...
(Date:1/15/2014)... 2013 was a banner year of ... They saw continued independent research led by the team ... a $1 million grant from the Susanne Marcus Collins ... a peer reviewed journal, Amy Grant highlighted Brainwave Optimization® ...
(Date:1/14/2014)... 2014 Date: Friday, April 11, 2014 , ... Club, 1360 Almshouse Road, Warrington, Pa. , Details: ... dedicated to finding a cure for hepatitis B and improving ... its annual Crystal Ball on Friday, April 11 at Warrington ...
Breaking Biology Technology:Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... Feb. 13 Crystal Research Associates, LLC,announced today ... (EIO(R)) on Bioniche Life Sciences Inc. (BNC: TSX). ... www.crystalra.com . , Bioniche ... a Canadian,biopharmaceutical company that aims to improve the ...
... Calif., Feb. 13 InterMune, Inc. (Nasdaq: ITMN ... of 3,500,000 shares of its common stock. The last ... Global Select Market on February 12, 2009 was $17.96. ... 19, 2009, subject to customary closing conditions. All of ...
... TAIAN CITY, Shandong, China, Feb. 13 /PRNewswire-Asia-FirstCall/ -- ... Biologic" or the,"Company"), one of the leading plasma-based ... today announced that one of its R&D,projects, "High-Purity ... Torch,Plan of China. , ...
Cached Biology Technology:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc. 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc. 3InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock 2China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan 2China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan 3